These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. Conway DS, Buggins P, Hughes E, Lip GY. J Am Coll Cardiol; 2004 Jun 02; 43(11):2075-82. PubMed ID: 15172416 [Abstract] [Full Text] [Related]
3. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion. Henningsen KM, Therkelsen SK, Bruunsgaard H, Krabbe KS, Pedersen BK, Svendsen JH. Scand J Clin Lab Invest; 2009 Jun 02; 69(3):425-32. PubMed ID: 19204850 [Abstract] [Full Text] [Related]
5. Source of inflammatory markers in patients with atrial fibrillation. Liuba I, Ahlmroth H, Jonasson L, Englund A, Jönsson A, Säfström K, Walfridsson H. Europace; 2008 Jul 02; 10(7):848-53. PubMed ID: 18523031 [Abstract] [Full Text] [Related]
6. Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation. Henningsen KM, Nilsson B, Bruunsgaard H, Chen X, Pedersen BK, Svendsen JH. Scand Cardiovasc J; 2009 Jul 02; 43(5):285-91. PubMed ID: 19117239 [Abstract] [Full Text] [Related]
7. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. Int J Cardiol; 2006 Apr 14; 108(3):346-53. PubMed ID: 15964643 [Abstract] [Full Text] [Related]
8. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Hatzinikolaou-Kotsakou E, Tziakas D, Hotidis A, Stakos D, Floros D, Papanas N, Chalikias G, Maltezos E, Hatseras DI. Am J Cardiol; 2006 Mar 01; 97(5):659-61. PubMed ID: 16490433 [Abstract] [Full Text] [Related]
9. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Ferro D, Loffredo L, Polimeni L, Fimognari F, Villari P, Pignatelli P, Fuster V, Violi F. Arterioscler Thromb Vasc Biol; 2007 Dec 01; 27(12):2763-8. PubMed ID: 17901373 [Abstract] [Full Text] [Related]
10. Frequency of elevation of C-reactive protein in atrial fibrillation. Anderson JL, Allen Maycock CA, Lappé DL, Crandall BG, Horne BD, Bair TL, Morris SR, Li Q, Muhlestein JB, Intermountain Heart Collaborative Study group. Am J Cardiol; 2004 Nov 15; 94(10):1255-9. PubMed ID: 15541240 [Abstract] [Full Text] [Related]
11. New-onset atrial fibrillation in bacteremia is not associated with C-reactive protein, but is an indicator of increased mortality during hospitalization. Kindem IA, Reindal EK, Wester AL, Blaasaas KG, Atar D. Cardiology; 2008 Nov 15; 111(3):171-80. PubMed ID: 18434721 [Abstract] [Full Text] [Related]
12. Inflammatory markers according to types of atrial fibrillation. Gedikli O, Dogan A, Altuntas I, Altinbas A, Ozaydin M, Akturk O, Acar G. Int J Cardiol; 2007 Aug 21; 120(2):193-7. PubMed ID: 17240468 [Abstract] [Full Text] [Related]
13. Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence. Rizos I, Rigopoulos AG, Kalogeropoulos AS, Tsiodras S, Dragomanovits S, Sakadakis EA, Faviou E, Kremastinos DT. J Hum Hypertens; 2010 Jul 21; 24(7):447-57. PubMed ID: 20072146 [Abstract] [Full Text] [Related]
14. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion. Loricchio ML, Cianfrocca C, Pasceri V, Bianconi L, Auriti A, Calo L, Lamberti F, Castro A, Pandozi C, Palamara A, Santini M. Am J Cardiol; 2007 May 15; 99(10):1421-4. PubMed ID: 17493472 [Abstract] [Full Text] [Related]
15. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E, PEACE Investigators. Circulation; 2007 Mar 27; 115(12):1528-36. PubMed ID: 17372173 [Abstract] [Full Text] [Related]
16. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion]. Zarauza J, Rodríguez Lera MJ, Fariñas Alvarez C, Hernando JP, Ceballos B, Gutiérrez B, Pérez J, Cuesta JM. Rev Esp Cardiol; 2006 Feb 27; 59(2):125-9. PubMed ID: 16540033 [Abstract] [Full Text] [Related]
17. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study. Tsivgoulis G, Spengos K, Zakopoulos N, Manios E, Peppes V, Vemmos K. Age Ageing; 2005 Jan 27; 34(1):35-40. PubMed ID: 15591481 [Abstract] [Full Text] [Related]
18. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. Ann Thorac Surg; 2005 May 27; 79(5):1530-5. PubMed ID: 15854929 [Abstract] [Full Text] [Related]
19. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. Anand DV, Lahiri A, Lim E, Hopkins D, Corder R. J Am Coll Cardiol; 2006 May 02; 47(9):1850-7. PubMed ID: 16682312 [Abstract] [Full Text] [Related]
20. Can perioperative C-reactive protein and interleukin-6 levels predict atrial fibrillation after coronary artery bypass surgery? Ziabakhsh-Tabari S. Saudi Med J; 2008 Oct 02; 29(10):1429-31. PubMed ID: 18946567 [Abstract] [Full Text] [Related] Page: [Next] [New Search]